Effects of dexamethasone and dexamethasone plus naltrexone on pituitary response to GnRH and TRH in normal women

Hormone Research

Volumn 51, Issue 2, 1999, Pages 85-90

  La Marca, Antonio ^b   Torricelli, Michela ^b   Morgante, Giuseppe ^b   Lanzetta, Danila ^b   De Leo, Vincenzo ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b NONE

Author keywords

Dexamethasone; Gonadotropin releasing hormone; Luteinizing hormone; Naltrexone; Prolactin; Thyrotropin releasing hormone

Indexed keywords

DEXAMETHASONE; ENDORPHIN; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE; NALTREXONE; PROLACTIN; PROTIRELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLITROPIN RELEASE; HUMAN; HYPOPHYSIS; LUTEINIZING HORMONE RELEASE; PRIORITY JOURNAL; PROLACTIN RELEASE;

EID: 0032978913     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023320     Document Type: Article

References (35)

1. Suh BY, Liu JH, Berga SL, Quigley ME, Laughlin GA, Yen SS: Hypercortisolism in patients with functional hypothalamic-amenorrhea. J Clin Endocrinol Metab 1988;66:733-739.
2. Ding JH, Sheckter CB, Drinkwater BL, Soules MR, Bremner WJ: High serum cortisol levels in exercise-associated amenorrhea. Ann Intern Med 1988;108:530-534.
3. Monzani A, Petraglia F, De Leo V, Fabbri G, D'Ambrogio G, Volpe A, Genazzani AR: Glucocorticoids but not vasopressin or oxytocin inhibit luteinizing hormone secretion in patients with psychogenic amenorrhea. Gynecol Endocrinol 1989;3:55-62.
4. De Kloet R, Wallach G, McEwen BS: Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology 1975;96:598-609.
5. Kononen J, Honkaniemi J, Gustafsson JA, Pelto Huikko M: Glucocorticoids receptor colocalization with pituitary hormones in the rat pituitary gland. Mol Cell Endocrinol 1993;93:97-103.
6. Cintra A, Fuxe K, Solfrini V, et al: Central peptidergic neurons as targets for glucocorticoid action. Evidence for the presence of glucocorticoid receptor immunoreactivity in various types of classes of peptidergic neurons. J Steroid Biochem Mol Biol 1991;40:93-103.
7. Ahima RS, Harlan RE: Glucocorticoid receptors in LHRH neurons. Neuroendocrinology 1992;56:845-850.
8. Chantaraprateep P, Thibier M: Effects of dexamethasone on the response of luteinizing hormone and testosterone to two injections of luteinizing hormone releasing hormone in young postpuberal bulls. J Endocrinol 1978;77: 389-395.
9. Melis GB, Mais V, Gambacciani M, Paoletti AM, Antinori D, Fioretti P: Dexamethasone reduces the post-castration gonadotropin rise in women. J Clin Endocrinol Metab 1987;65: 237-241.
10. Ringstrom SJ, Schwartz NB: Cortisol suppresses the LH, but not the FSH, response to gonadotropin-releasing hormone after orchidectomy. Endocrinology 1985;116:472-474.
11. Ringstrom SJ, Schwartz NB: Differential effect of glucocorticoids on synthesis and secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH). J Steroid Biochem 1987; 27:625-630.
12. Sakakura M, Takebe K, Nakagawa S: Inhibition of luteinizing hormone hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects. J Clin Endocrinol Metab 1975;40:774-779.
13. Baldwin DM, Sawyer CH: Effects of dexamethasone on LH release and ovulation in the cyclic rat. Endocrinology 1974;94:1397-1403.
14. Morrell JI, MacGinty JF, Pfaff DW: A subset of β-endorphin-and dynorphin-containing neurons in the medial basal hypothalamus accumulates estradiol. Neuroendocrinology 1985; 41:417-426.
15. Belhadj H, De Besi L, Bardin CW, Thau RB: The implication of opiates in the glucocorticoid-mediated inhibition of LH secretion. J Endocrinol 1989;122:451-456.
16. Briski KP, Vogel KL: Role of endogenous opioid peptides in central glucocorticoid receptor (GR)-induccd decreases in circulating LH in the male rat. Neuropeptides 1995;28:175-181.
17. Carjon RW, Salicioni AM, Deis RP: Regulation secretion by adrenal steroids in oestrogen-treated ovariectomized rats: Participation of endogenous opioid peptides. Neuropharmacology 1997;36:1433-1438.
18. Hangaard J, Andersen M, Grodum E, Koldkiaer O, Hagen C: Pulsatile luteinizing hormone secretion in patients with Addison's disease. Impact of glucocorticoid substitution. J Clin Endocrinol Metab 1998;83:736-743.
19. Kamel F, Kubajak CL: Modulation of gonadotropin secretion by corticosterone: Interaction with gonadal steroids and mechanism of action. Endocrinology 1987;121:561-568.
20. Hwan JC, Freeman MD: Partial purification of a hypothalamic factor that inhibits gonadotropin-releasing hormone-stimulated luteinizing hormone release. Endocrinology 1987;120: 483-490.
21. Stubbs WA, Jones A, Edwards CRW, Delitala G, Jeffcoate WJ, Rutter SJ, Besser GM, Bloom SR, Alberti KGM: Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet 1978;ii:1225-1227.
22. Von Graffenried B, Del Pozo E, Roubicek J, Krebs E, Poldinger W, Bumeister P, Kerp L: Effects of the synthetic enkephalin analogue FK 33-824 in man. Nature 1978;272:729-730.
23. Reid RL, Hoff JD, Yen SSC, Li CH: Effects of exogenous β-endorphin on pituitary hormone secretion and its disappearance rate in normal human subjects. J Clin Endocrinol Metab 1981;52:1179-1184.
24. Wilkes MM, Yen SSC: Reduction of β-endorphin on efflux of dopamine and DOPAC from superfused medial basal hypothalamus. Life Sci 1980;27:1387-1391.
25. Gudelsky GA, Porte JC: Morphine and opioid peptide-induced inhibition of the release of dopamine from tubero-infundibolar neurons. Life Sci 1979;25:1697-1702.
26. Janowsky D, Judd L, Huey L, Roitman N, Parker D, Segal D: Negative naloxone effects on serum prolactin. Lancet 1978;ii:637.
27. Delitala G, Devilla L, Arata L: Opiate receptors and anterior pituitary hormone secretion in man. Effect of naloxone infusion. Acta Endocrinol (Copenh) 1981;97:150-156.
28. Spiler IJ, Molitch ME: Lack of modulation of pituitary hormone stress response by neural pathways involving opiate receptors. J Clin Endocrinol Metab 1980;50:516-520.
29. Veldhuis JD, Worgul TJ, Monsaert R, Hammond JM: A possible role of endogenous opioids in the control of prolactin and luteinizing-hormone secretion in the human. J Endocrinol Invest 1981;4:31-36.
30. Delitala G, Giusti M, Montano V, Tarditi W, Bacelliere L, Rodriguez G, Rosadini GT, Giordano G: Growth hormone, prolactin and cortisol nyctohemeral variations during naloxone-induced opiate receptor blockade in man. Acta Endocrinol (Copenh) 1982;100:321-326.
31. Wakabayashi I, Demura R, Miki N, Ohmura E, Miyoshi H, Shizume K: Failure of naloxone to influence plasma growth hormone, prolactin, and cortisol secretion induced by insulin hypoglycemia. J Clin Endocrinol Metab 1980;50: 597-599.
32. Mayer G, Wessel J, Kobberling J: Failure of naloxone to alter exercise-induced growth hormone and prolactin release in normal men. Clin Endocrinol (Oxf) 1980;13:413-416.
33. Cetel NS, Quigley ME, Yen SSC: Naloxone-induced prolactin secretion in women: Evidence against a direct prolactin stimulatory effect of endogenous opioids. J Clin Endocrinol Metab 1985;60:191-196.
34. Yen SSC, Hoff JD, Lasley BL, Casper RF, Sheehan K: Induction of prolactin release by LRF and LRF-agonist. Life Sci 1980;26:1963-1966.
35. Denef C, Andries M: Evidence for paracrine interaction between gonadotrophs and lactotrophs in pituitary cell aggregates. Endocrinology 1983;112:813-822.